Lataa...
Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report
BACKGROUND: Nivolumab is a monoclonal antibody against programmed death 1 and has become a standard treatment of advanced melanoma because of its durable response and survival benefits. In this report, we present a case of severe intestinal perforation after nivolumab immunotherapy for malignant mel...
Tallennettuna:
| Julkaisussa: | Surg Case Rep |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Berlin Heidelberg
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572476/ https://ncbi.nlm.nih.gov/pubmed/28842844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-017-0370-7 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|